The analysis showed that NLR ≥ 1.520 (OR 11.119, p = 0.006), APRI ≥ 0.275 (OR 12.515, p = 0.009), tumor size > 3 cm (OR 7.689, p = 0.022), and AFP ≥ 200 μg/mL (OR 7.823, p = 0.016) were independent risk factors for MVI in patients with hepatoma (Table 3). The gene discussed is AFP; the disease is hepatocellular carcinoma.